Literature DB >> 24469592

Dopaminergic contributions to hippocampal pathophysiology in schizophrenia: a computational study.

Peter J Siekmeier1, David P vanMaanen1.   

Abstract

Since the original formulation of the dopamine hypothesis, a number of other cellular-level abnormalities--eg, NMDA receptor hypofunction, GABA system dysfunction, neural connectivity disturbances--have been identified in schizophrenia, but the manner in which these potentially interact with hyperdopaminergia to lead to schizophrenic symptomatology remains uncertain. Previously, we created a neuroanatomically detailed, biophysically realistic computational model of hippocampus in the control (unaffected) and schizophrenic conditions, implemented on a 72-processor supercomputer platform. In the current study, we apply the effects of dopamine (DA), dose-dependently, to both models on the basis of an exhaustive review of the neurophysiologic literature on DA's ion channel and synaptic level effects. To index schizophrenic behavior, we use the specific inability of the model to attune to the 40 Hz (gamma band) frequency, a finding that has been well replicated in the clinical electroencephalography (EEG) and magnetoencephalography literature. In trials using 20 'simulated patients', we find that DA applied to the control model produces modest increases in 40 Hz activity, similar to experimental studies. However, in the schizophrenic model, increasing DA induces a decrement in 40 Hz resonance. This modeling work is significant in that it suggests that DA's effects may vary based on the neural substrate on which it acts, and--via simulated EEG recordings-points to the neurophysiologic mechanisms by which this may occur. We also feel that it makes a methodological contribution, as it exhibits a process by which a large amount of neurobiological data can be integrated to run pharmacologically relevant in silico experiments, using a systems biology approach.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24469592      PMCID: PMC4023145          DOI: 10.1038/npp.2014.19

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

1.  Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors.

Authors:  F Liu; Q Wan; Z B Pristupa; X M Yu; Y T Wang; H B Niznik
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

2.  Characterization of dopamine D1 and D2 receptor-expressing neurons in the mouse hippocampus.

Authors:  Giuseppe Gangarossa; Sophie Longueville; Dimitri De Bundel; Julie Perroy; Denis Hervé; Jean-Antoine Girault; Emmanuel Valjent
Journal:  Hippocampus       Date:  2012-07-06       Impact factor: 3.899

3.  Sustained enhancement of AMPA receptor- and NMDA receptor-mediated currents induced by dopamine D1/D5 receptor activation in the hippocampus: an essential role of postsynaptic Ca2+.

Authors:  S N Yang
Journal:  Hippocampus       Date:  2000       Impact factor: 3.899

Review 4.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

Review 5.  The dopaminergic mesencephalic projections to the hippocampal formation in the rat.

Authors:  A Gasbarri; A Sulli; M G Packard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1997-01       Impact factor: 5.067

6.  Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.

Authors:  G Winterer
Journal:  Pharmacopsychiatry       Date:  2006-02       Impact factor: 5.788

7.  Dexamphetamine selectively increases 40 Hz auditory steady state response power to target and nontarget stimuli in healthy humans.

Authors:  Matthew A Albrecht; Greg Price; Joseph Lee; Rajan Iyyalol; Mathew T Martin-Iverson
Journal:  J Psychiatry Neurosci       Date:  2013-01       Impact factor: 6.186

8.  Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment.

Authors:  Dorea Vierling-Claassen; Peter Siekmeier; Steven Stufflebeam; Nancy Kopell
Journal:  J Neurophysiol       Date:  2008-02-20       Impact factor: 2.714

9.  The effect of repetitive transcranial magnetic stimulation on gamma oscillatory activity in schizophrenia.

Authors:  Mera S Barr; Faranak Farzan; Tamara Arenovich; Robert Chen; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

10.  Development of antipsychotic medications with novel mechanisms of action based on computational modeling of hippocampal neuropathology.

Authors:  Peter J Siekmeier; David P vanMaanen
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more
  1 in total

1.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.